Bitter taste phenotype better predicts folate status than tas2r38 bitter receptor genotype alone in a colonoscopy cohort  by Beckett, E.L. et al.
Abstracts / Journal of Nutrition & Intermediary Metabolism 1 (2014) 1e55 13conﬁdent’ (50.5%) to ‘very conﬁdent’ (15.5%) in providing nutritional rec-
ommendations; around one-third (29.0%) were ‘somewhat conﬁdent’.
Conclusions: Despite their conﬁdence in providing advice, GP trainees
demonstrated incomplete knowledge of nutritional recommendations.
Medical schools must provide doctors with crucial nutritional knowledge
to help prevent chronic disease in the community.
Funding source(s): The Almond Board of Australia.Concurrent session 3: gut health and nutrigenomics
PROBIOTIC YOGHURT AND INCIDENCE OF DIARRHOEA IN CHILDREN: A
DOUBLE BLIND, RANDOMISED, CONTROLLED TRIAL
M.J. Fox 1, K.D.K. Ahuja 1, I.K. Robertson 1, M.J. Ball 1, R.D. Eri 1. 1 School of
Health Sciences, University of Tasmania, Launceston, TAS, Australia
E-mail: foxmj@postofﬁce.utas.edu.au (M.J. Fox)
Background/Aims: To estimate the efﬁcacy of a probiotic yogurt
compared to a pasteurised yogurt for the prevention of antibiotic-associ-
ated diarrhoea in children.
Methods: This was a multisite, randomised, double-blind, placebo-
controlled clinical trial conducted between 2009-2012. Children aged 1-12
years on antibiotics were randomised to receive 200 g/day of either yogurt
(probiotic) containing Lactobacillus rhamnosus GG® (LGG®), Biﬁdobacterium
lactis® (Bb-12®) and Lactobacillus acidophilus® (La-5®) or apasteurizedyogurt
(placebo) for the duration of their antibiotic treatment. Stool frequency, and
consistency were recorded for the duration of treatment plus one week.
Primary outcomewas stool frequency and consistency, classiﬁed at different
levels of diarrhoea severity. Due to small number of cases of diarrhoea,
comparisons between groups were made using Fisher’s exact analysis.
Results: Seventy children completed the trial (36 placebo and 34 pro-
biotic). There were no incidents of severe diarrhoea (stool consistency 6,
 3 stools/day for  2 consecutive days) in the probiotic group and six in
the placebo group (p ¼ 0.025). There was also only one episode of minor
diarrhoea (stool consistency  5,  2 stools/day for  2 days) in the pro-
biotic group compared to 21 in the placebo group (p < 0.001). Probiotic
group reported fewer (one abdominal pain, one vomiting, one headache)
adverse events than the placebo group (six abdominal pain, four loss of
appetite, one nausea).
Conclusions: A yogurt combination of LGG®, La-5® and Bb-12® is an
effective method for reducing the incidence of antibiotic-associated diar-
rhoea in children.
Funding source(s): Parmalat Australia.
THE IMPACT OF GASTROINTESTINAL SYMPTOMS AND DERMATOLOGICAL
INJURIES ON NUTRITIONAL INTAKE DURING EXTREME ENDURANCE
EVENTS
R.J.S. Costa 1, V. Scheer 2, A. Murray 3. 1Department of Nutrition & Dietetics,
Monash University, Melbourne, Australia; 2British Forces Germany Health
Services, Detmold Medical Centre, 32756 Detmold, Germany; 3Centre of
Sports & Exercise, Edinburgh University, EH8 9TJ, Edinburgh, UK
E-mail: ricardo.costa@monash.edu (R.J.S. Costa)
Background/Aims: Gastrointestinal symptoms (GIS) and dermatological
injuries (DI) are commonly reported after endurance running. The current
studyaimed todeterminewhetherGIS andDI inﬂuencesnutritional intakeof
ultra-runners during a 230 km multi-stage ultra-marathon (MSUM) con-
ducted in hot conditions (32-40 ºC) and a 24-hours continuous (122-208 km
range) ultra-marathon (24h) conducted in temperate conditions (0-20 ºC).
Methods: Ad libitum food and ﬂuid intakes of ultra-runners (MSUM n ¼
74, 24h n ¼ 25) were recorded throughout competition in real-time and
analysed by dietary analysis software. A GIS and DI medical log was used to
monitor symptoms throughout both events. ANOVA was used to analyse
nutritional intake data between no-GIS vs. GIS, no-DI vs. DI; and severity of
symptoms and injuries.
Results: GIS were reported by 85% and 65% of ultra-runners throughout
MSUM and 24h, respectively. GIS during MSUM resulted in reduced total
daily, pre-stage, during, and post-stage energy (p¼ 0.04) andmacronutrientintakes (p ¼ 0.02); whereas GIS during 24h did not inﬂuence nutritional
variables. ThroughoutMSUMand24h, 76%and12%of ultra-runners required
medical intervention for DI, respectively. DI during MSUM resulted in
reduced total daily energy intake (p ¼ 0.05), carbohydrate (p ¼ 0.045) and
ﬂuid (p ¼ 0.016) intake during running, and protein intake post-stage (p ¼
0.045).DI throughout24hwas low, thus comparative analyseswasnot viable.
Conclusions: High rates of GIS were reported in both events; however GIS
only affected nutritional intake during MSUM, likely attributed to exer-
tional-heat stress. DI presence and severity reduce nutritional intake
during running and recovery in MSUM, suggesting DI prevention strate-
gies are warranted.
Funding source(s): N/A.
GLOBAL GENE TRANSCRIPT PROFILING REVEALS LACTOFERRIN
INTERVENTION INFLUENCES NEURAL DEVELOPMENT AND COGNITION
Y. Chen 1, Z.Q. Zheng 1, X. Zhu 1, Y.J. Shi 2, F.A. Troy, II 1,3, B. Wang 1,4. 1 School
of Medicine, Xiamen University, China; 2Nestle Research Center, Beijing,
China; 3Department of Biochemistry and Molecular Medicine, University of
California School of Medicine, Davis, USA; 4 School of Animal & Veterinary
Sciences, Charles Sturt University, Australia
E-mail: biwang@csu.edu.au (B. Wang)
Background/Aims: To test the hypothesis that lactoferrin (Lf) may induce
gene expression proﬁling and function to improve neurodevelopment and
cognition in postnatal piglets, an animal model for human infants.
Methods: Three-day-old male piglets were randomly allocated to two
groups. Group 1were fedmilk replacer supplemented with Lf at 0.6 g/L (n¼
17) and Group 2, 0.06 g/L (n ¼ 16; control). RNA was isolated from the hip-
pocampus of 10 piglets/group and subjected to transcript proﬁling using a
Porcine Affymetrix GeneChips representing 20,201 genes from Sus scrofa. A
TaqMan®Geneexpressionassaybasedreal-timePCRwasused tovalidate the
microarray ﬁndings. Results were analysed using Partek Genomics Suite 6.5
software and Ingenuity System (Ingenuity® System, Redwood City, CA, USA).
Results: A total of 1,187 genes were differentially expressed between the
control and Lf groups, based on our ﬁlter criteria (fold change: 1.15 and p <
0.05). A positive global effect of Lf on neurodevelopment and cognition
was observed, as evidenced by the modulation of a wide range of neuronal
processes including an increase in cellular protrusions, microtubule dy-
namics, formation and organization of neurite outgrowth, cytoskeleton
formation, and a decrease in anxiety. TaqMan® gene expression assays
which showed that Lf up-regulated the brain-derived neurotrophic factor
(BDNF) gene and signalling pathway known to inﬂuence early neuro-
development and cognition in postnatal mammals.
Conclusions: Lf supplementation up-regulated several canonical signal-
ling pathways associated with neurodevelopment and cognition, the
principal one being BDNF.
Funding source(s): Medical school of Xiamen University, China, Nestle
Research Centre-Beijing.
BITTER TASTE PHENOTYPE BETTER PREDICTS FOLATE STATUS THAN
TAS2R38 BITTER RECEPTOR GENOTYPE ALONE IN A COLONOSCOPY
COHORT
E.L. Beckett 1,2, M. Veysey 3, X. Ng 1, L. Boyd 1, S. Tang 1, Z. Yates 4, K.
Duesing 2, M. Lucock 1. 1 School of Environmental and Life Sciences,
University of Newcastle, NSW, Australia; 2 Food and Nutrition Flagship,
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NSW, Australia; 4 School of Biomedical Sciences and Pharmacy, University
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Background/Aims: TAS2R38 polymorphisms inﬂuence bitter taste
perception. Those sensitive to bitter tastes may consume less healthy
vegetables, resulting in a higher risk of diet-related disease. We assessed
the inﬂuence of TAS2R38 genotype and bitter taste phenotype on folate
intake and blood levels, as a marker of healthy vegetable consumption, and
if this inﬂuenced risk of adenomatous polyps (AP).
Methods: Blood was collected from colonoscopy patients (n ¼ 206).
Polymorphisms in the TAS2R38 gene were measured (Restriction fragment
length polymorphism-PCR/sequencing; A49P; rs713598, V262A: rs1726866,
Abstracts / Journal of Nutrition & Intermediary Metabolism 1 (2014) 1e5514I296V; rs10246939) and grouped by haplotype. Serum and red cell folate
levels (chemiluminescent immunoassay) and estimated folate intake (food
frequency questionnaires) were determined. 6-n-propylthiouracil solu-
tions were used to determine bitter taste phenotype (“taster”/”non-
taster”). Differences between groups were assessed by t-tests, c2 tests and
RR of AP.
Results: TAS2R38 haplotype signiﬁcantly, but only partially predicted
taster phenotype (r ¼ 0.43, c2¼35.5, p < 0.001). There were no signiﬁcant
differences in folate intake or red cell folate in those with the PAV haplo-
type, relative to those without. Those with the PAV haplotype had signif-
icantly higher serum folate (17.95 ± 0.88 vs. 21.17 ± 1.42 nmol/L, p ¼ ¼
0.046). “Tasters” consumed signiﬁcantly less folate (436.7 ± 15.7 vs. 521.0±
40.2 mg/d, p ¼ 0.021) and had lower serum (18.52 ± 0.08 vs. 22.34 ± 1.53
nmol/L, p¼ 0.024) and red cell folate (832.2 ± 32.7 vs. 973.4 ± 58.1 nmol/L,
p ¼ 0.030), compared to “Non-tasters”. Neither haplotype nor phenotype
alone predicted AP risk.
Conclusions: Folate status signiﬁcantly varies with phenotype, but not
haplotype, but neither adequately predicted AP. Phenotype may be
modiﬁed by additional factors (genetic, epigenetic, sociocultural), which
may inﬂuence the axis between diet and disease.
Funding source(s): CSIRO.
A NOVEL APPLICATION OF BREATH HYDROGEN AND METHANE
MONITORING IN NUTRITIONAL SCIENCE
N. O'Callaghan 1, G. Brinkworth 1, C. Delahunty 1, S. Trowell 1, R. Butler 2, M.
Noakes 1. 1CSIRO Transformational Biology Platform, University of South
Australia, Australia; 2 Sansom Institute for Health Research, University of
South Australia, Australia
E-mail: nathan.o'callaghan@csiro.au (N. O'Callaghan)
Background/Aims: Breath tests have great clinical utility in the diagnosis
and management of intestinal disease (i.e. Helicobacter pylori infection and
intestinal bacterial overgrowth). These breath tests are based on carbo-
hydrate malabsorption and require administration of a substrate in an
acute setting. To date, monitoring basal production of hydrogen and
methane during dietary interventions remain unexplored. We aim to
determine the dynamics of breath hydrogen and methane proﬁle of
overweight/obese adults with type 2 diabetes during weight loss on
different dietary patterns.
Methods: Individuals were randomly assigned to consume a hypocaloric,
low carbohydrate, low saturated fat diet (LC,14% of energy as carbohydrate,
28% protein, 58% fat; n ¼ 13) or an energy matched high carbohydrate, low
fat diet (HC, 53% carbohydrates, 17% protein, 30% fat; n ¼ 14) combined
with a structured exercise program for 12 weeks. Breath hydrogen and
methane were measured by BreathTracker at baseline, weeks 4, 8 and 12.
Results: Both groups had similar reductions inweight (LC 10.6%, HC 9.3%, p
¼ 0.39). Breath hydrogen was altered during the intervention (repeated
measures ANOVA: time p ¼ 0.388; diet  time p ¼ 0.011); The LC group
experienced signiﬁcant reductions in hydrogen (-8.9 ppm, p ¼ 0.013) at
week 12 and non-signiﬁcant change in the HC group (+1.7 ppm, p ¼ NS).
Methane tended to increase during the intervention in both diets (time p¼
0.078, diet  time p ¼ 0.3).
Conclusions: Changes in hydrogen and methane production occurred
following dietary intervention, likely via modulation of fermentation
patterns within gastrointestinal tract. Further investigation is required to
validate their utility and applicability as non-invasive biomarker in
nutritional interventions.
Funding source(s): N/A.
LOW FODMAP DIET e EFFICACY IN MANAGING ABDOMINAL SYMPTOMS
IN PATIENTS WITH ENDOMETRIOSIS
J. Moore 1, P.R. Gibson 1, R. Burgell 1. 1Department of Gastroenterology,
Monash University and Alfred Hospital, Melbourne, Australia
E-mail: judith.moore@monash.edu (J. Moore)
Background/Aims: Endometriosis is a chronic condition that is associated
with pelvic pain and bowel symptoms similar to those usually described as
IBS. While management for endometriosis is often pharmacological or
surgical, we hypothesised bowel symptoms might respond to dietarymanipulation as does IBS without endometriosis. We aim to determine the
response to a low FODMAP diet (LFD) of gastrointestinal symptoms in
patients with endometriosis and IBS and to compare responses with those
with IBS alone.
Methods: A consecutive cohort referred to a private IBS clinic in Christ-
church NZ between 2009 and 2013 prospectively completed a symptom
questionnaire. The data were interrogated in those with IBS (Rome III
criteria) with and without endometriosis. All received LFD advice by an
appropriately trained nurse consultant. The response to a LFD, deﬁned by
patient-reported outcome of > 50% improvement of symptoms, was
assessed. Difference between the groups was tested via Fishers exact test.
Results: Of 157 women with IBS, 56 (35%) had a concurrent diagnosis of
endometriosis. The median age of those with endometriosis was 32 as
opposed to those without where median age was 39 (p ¼ 0.014). However,
response was reported in 71% with endometriosis compared with 47% of
those without endometriosis (p ¼ 0.004).
Conclusions: The high rate of response to a LFD suggests that this
approach should be added to the repertoire of management strategies for
endometriosis. Why the response was poorer in those without endome-
triosis was not clear.
Funding source(s): N/A.
POSTPRANDIAL NUTRIGENOMIC PATHWAY ANALYSIS OF ADIPOSE
TISSUE IN MEN WITH METABOLIC SYNDROME (METS)
A.L. Dordevic 1,2, M.P. Bonham 1,2, A.E. Larsen 1, P. Gran 1, A.J. Sinclair 2,3, J.B.
Jowett 4, N. Konstantopoulos 3, D. Cameron-Smith 1,5. 1 School of Exercise &
Nutritional Science, Deakin University, Australia; 2Department Nutrition &
Dietetics, Monash University, Australia; 3Metbolic Research Unit, Deakin
University, Australia; 4Genomic & Systems Biology, Baker IDI, VIC,
Australia; 5 Liggins Institute, Auckland University, NZ, New Zealand
E-mail: aimee.dordevic@monash.edu (A.L. Dordevic)
Background/Aims: Proﬁling the transcriptomic regulation of adipose tis-
sue (AT) by dietary manipulation in MetS will elucidate therapeutic and
nutritional targets for chronic disease management.
Methods: Seventeen men (8 control; 9 MetS) were recruited to participate
in a controlled randomised, single-blinded crossover single meal study.
Participants consumed either a saturated fatty acid (FA)-rich breakfast or
an unsaturated FA-rich breakfast. AT biopsies were taken at baseline (0 h),
and 4 h following each test meal. Global gene expression proﬁling of the AT
was performed using Illumina HumanWG-6 v3 microarray chips followed
by gene set enrichment analysis (GSEA) using DAVID software. Pathways
were considered signiﬁcant with Expression Analysis Systematic Explorer
(EASE) score < 0.05 and a false discovery rate (FDR) value < 0.05.
Results: Two pathways that were differentially regulated in MetS
compared to control AT at baseline were also enriched by the following
meal consumption. The Lysosome pathway was up-regulated (p < 0.001)
and the Ribosome pathway was down-regulated (p < 0.001) in MetS AT
compared with controls at baseline. Control AT exhibited enrichment of
the Lysosome pathway with the SFA meal (p¼ 0.001) and MetS AT showed
enrichment of the Ribosome pathway after the UFA meal (p ¼ 0.02).
Conclusions: Lysosome and Ribosome pathways are impaired in MetS AT
and can be manipulated by alterations in meal composition. This ﬁnding is
important in the discovery of potential nutritional targets for chronic
metabolic disease.
Funding source(s): Dairy Health & Nutrition Consortium (DHNC).
REDUCED FODMAPS IN GLUTEN-FREE GRAINS MAY EXPLAIN THE
IMPROVED SYMPTOMS IN PEOPLE WITH IBS FOLLOWING A GLUTEN-
FREE DIET
J.G. Muir 1, J. Mills 1, D. Suter 2, F. Bekes 2, K. Liels 1, C.K. Yao 1, P.R.
Gibson 1. 1Department of Gastroenterology, Central Clinical School, Monash
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Background/Aims: Individuals with IBS blame gluten-containing grains for
triggering gastrointestinal symptoms. Another component of grains that
requires consideration is the FODMAPs mostly fructans and galacto-olig-
saccharides (GOS). We aim to analyse the gluten and FODMAP content of 22
